ATE255900T1 - Verwendung von wenigsten einem fukan zur herstellung eines arzneimittels für die behandlung pariodontaler erkrankungen - Google Patents
Verwendung von wenigsten einem fukan zur herstellung eines arzneimittels für die behandlung pariodontaler erkrankungenInfo
- Publication number
- ATE255900T1 ATE255900T1 AT98962487T AT98962487T ATE255900T1 AT E255900 T1 ATE255900 T1 AT E255900T1 AT 98962487 T AT98962487 T AT 98962487T AT 98962487 T AT98962487 T AT 98962487T AT E255900 T1 ATE255900 T1 AT E255900T1
- Authority
- AT
- Austria
- Prior art keywords
- fucan
- treatment
- production
- medicinal product
- periodontal diseases
- Prior art date
Links
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 230000002500 effect on skin Effects 0.000 abstract 2
- 210000002950 fibroblast Anatomy 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 102000005741 Metalloproteases Human genes 0.000 abstract 1
- 108010006035 Metalloproteases Proteins 0.000 abstract 1
- 102000016387 Pancreatic elastase Human genes 0.000 abstract 1
- 108010067372 Pancreatic elastase Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 230000003239 periodontal effect Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9716080A FR2772618B1 (fr) | 1997-12-18 | 1997-12-18 | Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs |
| PCT/FR1998/002758 WO1999032099A2 (fr) | 1997-12-18 | 1998-12-17 | Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE255900T1 true ATE255900T1 (de) | 2003-12-15 |
Family
ID=9514785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98962487T ATE255900T1 (de) | 1997-12-18 | 1998-12-17 | Verwendung von wenigsten einem fukan zur herstellung eines arzneimittels für die behandlung pariodontaler erkrankungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6559131B1 (de) |
| EP (1) | EP1039916B8 (de) |
| JP (1) | JP4589528B2 (de) |
| AT (1) | ATE255900T1 (de) |
| AU (1) | AU1764999A (de) |
| BR (1) | BR9813778A (de) |
| DE (1) | DE69820480T2 (de) |
| ES (1) | ES2212833T3 (de) |
| FR (1) | FR2772618B1 (de) |
| WO (1) | WO1999032099A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001074320A2 (de) * | 2000-03-31 | 2001-10-11 | Henkel Kommanditgesellschaft Auf Aktien | Verwendung von protease-inhibitoren in der kosmetik und pharmazie |
| US6812220B2 (en) | 2001-08-29 | 2004-11-02 | University Of British Columbia | Pharmaceutical compositions and methods relating to fucans |
| AU2007200318B2 (en) * | 2001-08-29 | 2009-06-18 | The University Of British Columbia | Use of fucans in the treatment of adhesions, arthritis and psoriasis |
| US20070238697A1 (en) * | 2001-08-29 | 2007-10-11 | University Of British Columbia | Pharmaceutical compositions and methods relating to fucans |
| EP1870105A1 (de) * | 2001-08-29 | 2007-12-26 | The University of British Columbia | Verwendung von Fucanen bei der Behandlung von Psoriasis |
| PT1809303T (pt) * | 2004-09-23 | 2019-06-17 | Arc Medical Devices Inc | Composições farmacêuticas e métodos relacionados para inibir aderências fibrosas ou doença inflamatória com a utilização de fucanos com baixo teor de sulfato |
| FR2882258B1 (fr) * | 2005-02-22 | 2009-01-16 | Oreal | Utilisation capillaire de polysaccharides sulfates |
| FR2897538B1 (fr) | 2006-02-23 | 2008-05-02 | Univ Paris Descartes | Utilisation de fucanes a des fins de greffe, d'ingenierie et de regeneration osseuses |
| CN101368178B (zh) * | 2007-08-16 | 2010-07-21 | 浙江大学 | 罗氏沼虾精子类明胶酶及其编码基因和应用 |
| WO2010086696A1 (en) | 2009-01-28 | 2010-08-05 | Therapol | Low-molecular-weight sulphated polysaccharides as candidates for anti-angiogenic therapy |
| JO3676B1 (ar) * | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
| US20120310210A1 (en) | 2011-03-04 | 2012-12-06 | Campbell Carey V | Eluting medical devices |
| US9415193B2 (en) | 2011-03-04 | 2016-08-16 | W. L. Gore & Associates, Inc. | Eluting medical devices |
| JP5946253B2 (ja) * | 2011-08-10 | 2016-07-06 | ロート製薬株式会社 | 弾性線維形成促進剤 |
| FR3020570B1 (fr) * | 2014-04-30 | 2017-07-21 | Pierre Fabre Dermo-Cosmetique | Association d'un acide hyaluronique et d'un polysaccharide sulfate |
| US10569063B2 (en) | 2014-10-03 | 2020-02-25 | W. L. Gore & Associates, Inc. | Removable covers for drug eluting medical devices |
| FR3056911B1 (fr) | 2016-10-03 | 2019-07-19 | Ys Lab | Composition aqueuse derivee d’eau de mer et d’algues marines |
| FR3113236B1 (fr) | 2020-08-05 | 2024-10-04 | Algues Et Mer | Fraction purifiée de fucoïdanes pour la préparation de compositions cosmétiques et/ou dermatologiques anti-age. |
| WO2024243672A1 (en) * | 2023-05-31 | 2024-12-05 | ARC Medical Inc. | Compositions and methods relating to fucans and modified fucans for the treatment of various medical conditions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6431707A (en) * | 1987-07-28 | 1989-02-02 | Nikko Chemicals | Dermal agent for external use |
| FR2648463B1 (fr) * | 1989-06-14 | 1993-01-22 | Inst Fs Rech Expl Mer | Polysaccharides sulfates, agent anticoagulant et agent anticomplementaire obtenus a partir de fucanes d'algues brunes et leur procede d'obtention |
| IT1275881B1 (it) | 1995-03-09 | 1997-10-24 | Res Pharma Srl | Polianioni di origine non animale ad attivita' dermatologica e tricogena |
| FR2738009B1 (fr) * | 1995-08-24 | 1997-10-31 | Centre Nat Rech Scient | Procede d'obtention de polysaccharides sulfates |
| JP3914284B2 (ja) * | 1996-07-01 | 2007-05-16 | 株式会社ヤクルト本社 | 線維芽細胞増殖因子複合体 |
| JPH1121247A (ja) * | 1997-06-30 | 1999-01-26 | Lion Corp | 皮膚賦活剤及びアレルギー抑制剤 |
-
1997
- 1997-12-18 FR FR9716080A patent/FR2772618B1/fr not_active Expired - Fee Related
-
1998
- 1998-12-17 AU AU17649/99A patent/AU1764999A/en not_active Abandoned
- 1998-12-17 BR BR9813778-6A patent/BR9813778A/pt not_active Application Discontinuation
- 1998-12-17 EP EP19980962487 patent/EP1039916B8/de not_active Expired - Lifetime
- 1998-12-17 US US09/581,810 patent/US6559131B1/en not_active Expired - Fee Related
- 1998-12-17 WO PCT/FR1998/002758 patent/WO1999032099A2/fr active IP Right Grant
- 1998-12-17 ES ES98962487T patent/ES2212833T3/es not_active Expired - Lifetime
- 1998-12-17 DE DE69820480T patent/DE69820480T2/de not_active Expired - Lifetime
- 1998-12-17 JP JP2000525090A patent/JP4589528B2/ja not_active Expired - Fee Related
- 1998-12-17 AT AT98962487T patent/ATE255900T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1764999A (en) | 1999-07-12 |
| US6559131B1 (en) | 2003-05-06 |
| WO1999032099A2 (fr) | 1999-07-01 |
| FR2772618B1 (fr) | 2000-02-18 |
| EP1039916A2 (de) | 2000-10-04 |
| WO1999032099A3 (fr) | 1999-09-10 |
| ES2212833T3 (es) | 2004-08-01 |
| JP4589528B2 (ja) | 2010-12-01 |
| EP1039916B8 (de) | 2004-04-21 |
| DE69820480T2 (de) | 2004-10-07 |
| BR9813778A (pt) | 2000-10-24 |
| JP2001526309A (ja) | 2001-12-18 |
| FR2772618A1 (fr) | 1999-06-25 |
| EP1039916B1 (de) | 2003-12-10 |
| DE69820480D1 (de) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE255900T1 (de) | Verwendung von wenigsten einem fukan zur herstellung eines arzneimittels für die behandlung pariodontaler erkrankungen | |
| ATE332702T1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
| DE60004974D1 (de) | Verwendung von xenon zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von neurovergiftungen | |
| ATE330593T1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
| ATE315050T2 (de) | Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten | |
| DE69628296D1 (de) | Verwendung von sophorolipiden zur herstellung kosmetischer produkte, insbesondere zur behandlung der haut | |
| ATE284693T1 (de) | Verwendung von dopamin-d 3-rezeptorantagonisten zur herstellung von arzneimittel für die behandlung von nierenfunktionsstörungen | |
| ATE249828T1 (de) | Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen | |
| ATE269077T1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
| ATE311853T1 (de) | Verwendung von krillenzymen zur behandlung von zahnbelag | |
| ATE219670T1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
| ATE272404T1 (de) | Verwendung von taurolidine zur herstellung eines arzneimittels zur behandlung von leukämien | |
| ATE221763T1 (de) | Die verwendung von glyceryltriacetat zur behandlung von onychomykosen | |
| DE69637449D1 (de) | Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen | |
| DE69635298D1 (de) | Verwendung von Acetylsalicylsäuren zur Herstellung eines Medikaments für die Behandlung von Hautverletzungen | |
| DE69921662D1 (de) | Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose | |
| ATE246518T1 (de) | Egr-1 zur herstellung eines medikamentes zur behandlung von wunden | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| ATE216235T1 (de) | Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie | |
| DE69003960D1 (de) | Die Verwendung von deacetyliertem Chitin zur Herstellung eines Medikamentes für die Behandlung von entzündliche Krankheiten. | |
| ATE234613T1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| DE69701258D1 (de) | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems | |
| ATE548048T1 (de) | Oncomodulin zur behandlung von neurologishen erkrankungen | |
| DE60043648D1 (de) | Medikamente zur behandlung von periodontalen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |